Skip to content

Clinical trials

Terminated Observational Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Observational Status: Terminated Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Nīmes1
National Institutes of Health Clinical Center (CC)1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia3
Burkitt Lymphoma2
Congenital Abnormalities2
Hodgkin Disease2
Leukemia, Hairy Cell2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2
Leukemia, Prolymphocytic2
Lymphoma2
Lymphoma, B-Cell, Marginal Zone2

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.